Alliancebernstein L.P. trimmed its holdings in shares of AMETEK, Inc. (NYSE:AME - Free Report) by 4.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 275,504 shares of the technology company's stock after selling 12,837 shares during the quarter. Alliancebernstein L.P. owned 0.12% of AMETEK worth $47,425,000 at the end of the most recent reporting period.
Several other hedge funds have also recently made changes to their positions in the business. Bares Capital Management Inc. purchased a new stake in AMETEK during the first quarter valued at approximately $26,000. Olde Wealth Management LLC purchased a new stake in AMETEK during the 1st quarter valued at $29,000. Annis Gardner Whiting Capital Advisors LLC raised its holdings in AMETEK by 57.7% during the 1st quarter. Annis Gardner Whiting Capital Advisors LLC now owns 194 shares of the technology company's stock valued at $33,000 after buying an additional 71 shares during the period. Minot DeBlois Advisors LLC purchased a new stake in AMETEK during the 4th quarter valued at $43,000. Finally, Zions Bancorporation National Association UT purchased a new stake in AMETEK during the 1st quarter valued at $42,000. 87.43% of the stock is currently owned by hedge funds and other institutional investors.
AMETEK Trading Down 1.0%
AME stock traded down $1.83 during mid-day trading on Friday, reaching $190.20. The company had a trading volume of 187,291 shares, compared to its average volume of 1,345,486. AMETEK, Inc. has a 12 month low of $145.02 and a 12 month high of $198.33. The company has a market capitalization of $43.93 billion, a PE ratio of 30.62, a price-to-earnings-growth ratio of 2.69 and a beta of 1.10. The firm has a 50 day moving average of $183.14 and a 200 day moving average of $177.19. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.63 and a quick ratio of 1.04.
AMETEK (NYSE:AME - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The technology company reported $1.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.69 by $0.09. AMETEK had a return on equity of 16.53% and a net margin of 20.60%.The company had revenue of $1.78 billion for the quarter, compared to analysts' expectations of $1.74 billion. During the same quarter in the prior year, the firm earned $1.66 earnings per share. AMETEK's revenue was up 2.5% compared to the same quarter last year. AMETEK has set its Q3 2025 guidance at 1.720-1.760 EPS. FY 2025 guidance at 7.060-7.200 EPS. On average, equities analysts predict that AMETEK, Inc. will post 7.15 earnings per share for the current fiscal year.
AMETEK Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Monday, September 15th will be issued a dividend of $0.31 per share. This represents a $1.24 annualized dividend and a yield of 0.7%. The ex-dividend date is Monday, September 15th. AMETEK's dividend payout ratio is presently 19.97%.
Analysts Set New Price Targets
Several equities research analysts have recently weighed in on the stock. Barclays assumed coverage on shares of AMETEK in a research note on Wednesday. They issued an "equal weight" rating and a $200.00 target price on the stock. TD Cowen upgraded shares of AMETEK from a "sell" rating to a "hold" rating and upped their price target for the company from $158.00 to $180.00 in a report on Tuesday, September 2nd. DA Davidson boosted their target price on AMETEK from $210.00 to $215.00 and gave the company a "buy" rating in a research report on Friday, August 1st. Mizuho upped their target price on AMETEK from $212.00 to $225.00 and gave the company an "outperform" rating in a research note on Friday, August 1st. Finally, Melius cut AMETEK from a "buy" rating to a "hold" rating and set a $192.00 target price on the stock. in a research note on Monday, July 14th. Seven research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $205.00.
Check Out Our Latest Stock Analysis on AMETEK
AMETEK Profile
(
Free Report)
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.
Further Reading

Before you consider AMETEK, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMETEK wasn't on the list.
While AMETEK currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.